Vancouver, British Columbia--(Newsfile Corp. - February 1, 2016) - True Leaf Medicine International Ltd. (CSE: MJ) ("the company") has extended its retail channels for its innovative hemp-based dog chews, effectively covering all 10 Canadian provinces and the three territories.

The company has increased the number of stores in British Columbia, Alberta and Ontario, a 35% increase in its retail distribution network. At the same time, True Leaf has added e-commerce to its web site, www.trueleaf.com. Retailing for $14.99 a package, True Leaf's line of dog chews: TrueCalmTM, TrueSpiritTM and TrueLoveTM, is now available in 47 independent pet stores and chains.

The new trueleaf.com e-commerce channel offers a flat shipping rate of $10 to anywhere in Canada for smaller orders, and free shipping on orders over $49.

Now, dog owners in every area of Canada can purchase hemp-based dog chews that provide healthy hip and joint, calming and antioxidant support to their dogs.

"This is great news both for True Leaf, and for pet lovers across Canada," said True Leaf CEO Darcy Bomford. "We now have a larger concentration of retail stores on the east and west coast, but still a gap in local retail distribution in central and northern Canada. Our e-commerce site bridges this gap."

This milestone aligns with True Leaf's Quality of Life value proposition as it continues to grow its market presence in the $60 billion pet industry with their line of pet products focused on hemp nutrition. In the weeks to come, True Leaf expects to offer its products via natural health and veterinary channels in Canada and the US.

About True Leaf International Ltd:

True Leaf Medicine International Ltd. has filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a licensed producer with a facility located in the Village of Lumby, BC. The company has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting a 'ready-to-build' approval.

Contact:

Kevin Bottomley
Director
True Leaf Medicine International Ltd
M: +1 778 389 9933
kevin@trueleaf.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. 

FORWARD LOOKING INFORMATION

This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.